Does metoprolol succinate sustained-release tablets have any effect on the kidneys?
Aug 03, 2023
Source: Cainiu Health
Dr. Tian Hongbo
Introduction
Under normal circumstances, metoprolol succinate sustained-release tablets have no effect on the kidneys. Metoprolol succinate sustained-release tablets are a beta-blocker, whose main active ingredient, metoprolol succinate, selectively blocks β1-receptors, effectively slowing heart rate, suppressing cardiac contraction, reducing cardiac automaticity, and prolonging atrioventricular conduction time.
Under normal circumstances, metoprolol succinate sustained-release tablets have no effect on the kidneys. The detailed analysis is as follows:
Metoprolol succinate sustained-release tablets are a type of beta-blocker. The main active ingredient, metoprolol succinate, selectively blocks β1-receptors, effectively slowing heart rate, suppressing cardiac contraction, reducing cardiac automaticity, and delaying atrioventricular conduction time. It is currently considered a relatively effective medication for treating hypertension. It is known that while exerting its blocking effects, metoprolol succinate is easily absorbed by the body. After absorption, renal function has no significant impact on the clearance of the drug components. Therefore, the drug has minimal effects on liver and kidney function, and even patients with impaired renal function generally do not require dose adjustments when taking this medication.
In summary, in most patients, metoprolol succinate sustained-release tablets do not affect kidney function. However, it should be noted that this medication may cause side effects in other aspects. Therefore, patients should always consult a qualified physician before starting the medication.
